Literature DB >> 20871122

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.

Johanna R Feary1, Laura C Rodrigues, Christopher J Smith, Richard B Hubbard, Jack E Gibson.   

Abstract

BACKGROUND: Comorbidities associated with systemic inflammation including cardiovascular disease (CVD), stroke and diabetes mellitus (DM) are common among individuals with chronic obstructive pulmonary disease (COPD). A study was undertaken to quantify the burden of comorbidity and to determine the risk of first acute arteriovascular events among individuals with COPD.
METHODS: The computerised primary care records of 1,204,100 members of the general population aged ≥ 35 years on 25 February 2005 were searched for recordings of each disease. Data were analysed using multivariate logistic regression. Cox regression was used to determine whether individuals with COPD were at increased risk of acute myocardial infarction (MI) and stroke.
RESULTS: Cross-sectional analyses showed that physician-diagnosed COPD was associated with increased risks of CVD (OR 4.98, 95% CI 4.85 to 5.81; p<0.001), stroke (OR 3.34, 95% CI 3.21 to 3.48; p<0.001) and DM (OR 2.04, 95% CI 1.97 to 2.12; p<0.001). In the follow-up analyses, after adjusting for confounding by sex and smoking status and stratifying for age, the greatest increase in the rate of acute arteriovascular events was found in the youngest age groups; the HR for acute MI was 10.34 (95% CI 3.28 to 32.60; p<0.001) and for stroke the HR was 3.44 (95% CI 0.85 to 13.84; p<0.001) compared with the oldest age group.
CONCLUSION: Individuals with COPD are substantially more likely to have pre-existing CVD, DM or a previous stroke and are at high risk of acute arteriovascular events. National COPD guidelines and models of care need to adapt to provide an integrated approach to addressing these comorbidities.

Entities:  

Mesh:

Year:  2010        PMID: 20871122     DOI: 10.1136/thx.2009.128082

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  125 in total

Review 1.  Chronic obstructive pulmonary disease: consequences beyond the lung.

Authors:  Dinesh Shrikrishna; Nicholas S Hopkinson
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

2.  Roflumilast: a green signal is yet to come.

Authors:  Nazir Lone; Yuji Oba
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 3.  The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Wassim W Labaki; Carlos H Martinez; Fernando J Martinez; Craig J Galbán; Brian D Ross; George R Washko; R Graham Barr; Elizabeth A Regan; Harvey O Coxson; Eric A Hoffman; John D Newell; Douglas Curran-Everett; James C Hogg; James D Crapo; David A Lynch; Ella A Kazerooni; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  Detecting time-evolving phenotypic topics via tensor factorization on electronic health records: Cardiovascular disease case study.

Authors:  Juan Zhao; Yun Zhang; David J Schlueter; Patrick Wu; Vern Eric Kerchberger; S Trent Rosenbloom; Quinn S Wells; QiPing Feng; Joshua C Denny; Wei-Qi Wei
Journal:  J Biomed Inform       Date:  2019-08-22       Impact factor: 6.317

5.  Measuring cardiovascular risk in COPD; child's play or MENSA?

Authors:  K J Rothnie; J K Quint
Journal:  Chron Respir Dis       Date:  2016-06-09       Impact factor: 2.444

6.  Characteristics of COPD Patients Using United States Emergency Care or Hospitalization.

Authors:  Suchit D Kumbhare; Tatsiana Beiko; Susan R Wilcox; Charlie Strange
Journal:  Chronic Obstr Pulm Dis       Date:  2016-03-28

7.  Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco.

Authors:  Rafael Golpe; Pilar Sanjuán-López; Irene Martín-Robles; Carlos González-Juanatey; Luis Pérez-de-Llano; José L López-Campos
Journal:  Lung       Date:  2018-02-12       Impact factor: 2.584

8.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Authors:  Martin Söderholm; Malin Inghammar; Bo Hedblad; Arne Egesten; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2015-12-28       Impact factor: 8.082

9.  Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008.

Authors:  Nirupama Putcha; Milo A Puhan; Nadia N Hansel; M Brad Drummond; Cynthia M Boyd
Journal:  COPD       Date:  2013-06       Impact factor: 2.409

10.  Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study.

Authors:  Solrun Bjork Runarsdottir; Gunnar Gudmundsson; Thor Aspelund; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Thorarinn Gislason
Journal:  COPD       Date:  2013-04-05       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.